Skip to content

About usNews

July 10, 2025

Press about the brands

Fontanka: why cosmetics sales moved online

On July 10, 2025, Fontanka.ru held a roundtable on how cosmetics sales channels are changing: why the mass market is moving to marketplaces, while expertise, formulas, and service are growing in the mid-tier and premium segments. ALMEA was represented by Evgenia Tkacheva, then marketing director for the XLASH brand.

She described the move to local manufacturing: “At the end of 2024, together with our Swedish partners, we opened a plant in Saint Petersburg so we could control the process ourselves and deepen our expertise in formulas.”

ALMEA’s position on sales channels is straightforward: marketplaces lead right now, but commissions are rising, so it matters to grow our own sales, including through the company website. “The purchase has to be as convenient as on a marketplace,” Evgenia Tkacheva said. “We do not have stores of our own: we develop sales through retail chains, and so far we still see that offline demand is much lower than online.”

She also stressed work with experts, bloggers, cosmetologists, and dermatologists — and a community trend even in the mass segment: at a product price of 200–300 rubles, collaborations with mini-influencers often pay off better than direct advertising. “Every kind of communication has to work together. You cannot rely on experts alone — every channel has a ceiling.”

On the risk of a first purchase: the company makes cosmetic serums for lashes, brows, and hair in 6.5 ml and 3.5 ml, and had considered a 1.5 ml format “so a customer could try it, see a result, and then buy the larger version. Because spending 1,000 rubles is easier than spending 3,000.”

At the end of the discussion, Evgenia Tkacheva warned against the illusion that experts will become the only main channel: “Growing sales on our own website matters too — it is direct communication with the customer, and it lets us adapt the product based on feedback.” She also raised counterfeits on marketplaces: fake listings that claim to be the XLASH brand damage the manufacturer’s reputation, even though the clinical studies and the investment in quality stay on the company’s side.

The full roundtable is on the Fontanka website.